BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), today announced that management will participate in Citi’s 13th Annual Biotech Conference on December 5 in New York City.
|
SAN RAFAEL, Calif., /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), today announced that management will participate in Citi's 13th Annual Biotech Conference on December 5 in New York City. To access the live webcast, please visit the investor section of the BioMarin website, www.biomarin.com. A replay will also be archived on the site for at least one week following each event.
About BioMarin BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of seven commercialized products and multiple clinical and pre-clinical product candidates. For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.
SOURCE BioMarin Pharmaceutical Inc. |
||||||||||||
Company Codes: NASDAQ-NMS:BMRN |
View original content to download multimedia:
